---
title: "Daily Hong Kong Stock Market News Briefing (December 16, Monday)"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/222379230.md"
description: "Daily Hong Kong Stock Market News Brief: R&F PROPERTIES had a contract sales amount of RMB 1 billion in November, with a cumulative total of RMB 10.19 billion from January to November; SHIMAO GROUP received 80.72% creditor support for restructuring; Guming Holdings resubmitted pre-listing documents; Ping An Insurance's premium income for the first eleven months reached RMB 796.3966 billion, a year-on-year increase of 7.86%; NCI's premium income for the first eleven months was RMB 163.1663 billion, a year-on-year increase of 2.2%; China Shenhua's coal sales volume for the first eleven months was 422 million tons, a year-on-year increase of 3%; Ganfeng Lithium's Goulamina lithium spodumene project commenced production; Shijiazhuang Fourth Pharmaceutical Group's related drugs were approved by the National Medical Products Administration"
datetime: "2024-12-16T01:05:49.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/222379230.md)
  - [en](https://longbridge.com/en/news/222379230.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/222379230.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/222379230.md) | [English](https://longbridge.com/en/news/222379230.md)


# Daily Hong Kong Stock Market News Briefing (December 16, Monday)

Individual Stock News

1.  R&F PROPERTIES (02777.HK): Contract sales in November amounted to RMB 1 billion, with cumulative contract sales from January to November reaching RMB 10.19 billion.
    
2.  SHIMAO GROUP (00813.HK): Creditors holding 80.72% of the debt principal within the scope support the restructuring.
    
3.  On December 15, Gu Ming Holdings re-submitted its pre-listing documents to the Hong Kong Stock Exchange.
    
4.  Ping An Insurance (02318.HK): The total premium income from original insurance contracts for the first 11 months was approximately RMB 796.3966 billion, a year-on-year increase of 7.86%.
    
5.  NCI (01336.HK): The cumulative original premium income for the first 11 months was RMB 163.1663 billion, a year-on-year increase of 2.2%.
    
6.  CSEC/China Shenhua (01088.HK): Coal sales for the first 11 months reached 422 million tons, a year-on-year increase of 3%.
    
7.  Ganfeng Lithium (01772.HK): The first phase of the Goulamina spodumene project has officially commenced production.
    
8.  Stone Four Pharmaceutical Group (02005.HK): Fumaric acid vorinostat and hydrochloride decitabine have been approved for registration by the National Medical Products Administration as raw materials for use in marketed formulations

### 相關股票

- [NCI (601336.CN)](https://longbridge.com/zh-HK/quote/601336.CN.md)
- [NCI (01336.HK)](https://longbridge.com/zh-HK/quote/01336.HK.md)
- [CSEC/China Shenhua (601088.CN)](https://longbridge.com/zh-HK/quote/601088.CN.md)
- [China Shenhua Energy (CSUAY.US)](https://longbridge.com/zh-HK/quote/CSUAY.US.md)
- [CHINA SHENHUA (01088.HK)](https://longbridge.com/zh-HK/quote/01088.HK.md)
- [R&F PROPERTIES (02777.HK)](https://longbridge.com/zh-HK/quote/02777.HK.md)
- [SHIMAO GROUP (00813.HK)](https://longbridge.com/zh-HK/quote/00813.HK.md)
- [NAYUKI (02150.HK)](https://longbridge.com/zh-HK/quote/02150.HK.md)
- [GANFENGLITHIUM (01772.HK)](https://longbridge.com/zh-HK/quote/01772.HK.md)
- [SH PHARMA (02607.HK)](https://longbridge.com/zh-HK/quote/02607.HK.md)
- [SHYNDEC (600420.CN)](https://longbridge.com/zh-HK/quote/600420.CN.md)
- [HEYTEA (HEYTEA.NA)](https://longbridge.com/zh-HK/quote/HEYTEA.NA.md)
- [Hengrui Pharma (600276.CN)](https://longbridge.com/zh-HK/quote/600276.CN.md)
- [TENGEN (003003.CN)](https://longbridge.com/zh-HK/quote/003003.CN.md)
- [PING AN (02318.HK)](https://longbridge.com/zh-HK/quote/02318.HK.md)
- [SSY GROUP (02005.HK)](https://longbridge.com/zh-HK/quote/02005.HK.md)
- [China Meheco (600056.CN)](https://longbridge.com/zh-HK/quote/600056.CN.md)
- [TIBET AIM PHARM (002826.CN)](https://longbridge.com/zh-HK/quote/002826.CN.md)
- [TY PHAR. (002728.CN)](https://longbridge.com/zh-HK/quote/002728.CN.md)
- [Lifeon Pharmaceutical (003020.CN)](https://longbridge.com/zh-HK/quote/003020.CN.md)

## 相關資訊與研究

- [A Look At China Life Insurance (SEHK:2628) Valuation After Strong 2025 Earnings And Proposed Final Dividend](https://longbridge.com/zh-HK/news/281251717.md)
- [Guangzhou R&F Properties Revamps Board and Committees Ahead of 2026 AGM](https://longbridge.com/zh-HK/news/281182304.md)
- [China Cinda Asset Management FY net profit attributable rmb3,562.3 million](https://longbridge.com/zh-HK/news/281172966.md)
- [Ping An targets doubling valuation as 60% of claims go automated](https://longbridge.com/zh-HK/news/281231549.md)
- [China Shenhua Sets 2026 Plan to Boost Value, Output and Technological Edge](https://longbridge.com/zh-HK/news/281061064.md)